NM_000748.3:c.2T>A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_000748.3(CHRNB2):c.2T>A(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000748.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNB2 | ENST00000368476.4 | c.2T>A | p.Met1? | start_lost | Exon 1 of 6 | 1 | NM_000748.3 | ENSP00000357461.3 | ||
CHRNB2 | ENST00000637900.1 | c.2T>A | p.Met1? | start_lost | Exon 1 of 6 | 5 | ENSP00000490474.1 | |||
CHRNB2 | ENST00000636034.1 | n.2T>A | non_coding_transcript_exon_variant | Exon 1 of 9 | 5 | ENSP00000489703.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1441432Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 715796
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: CHRNB2 c.2T>A (p.Met1?, aka p.Met1Lys) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. The first potential downstream in-frame start codon (ATG) is located at Met61, which is not a known initiation codon in alternative transcripts. To our knowledge, no pathogenic missense/in-frame variants have been reported upstream of Met61 (ClinVar). The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position, however other start-loss variants are reported in heterozygous carriers. To our knowledge, no occurrence of c.2T>A in individuals affected with Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 3 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1475973). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Autosomal dominant nocturnal frontal lobe epilepsy Uncertain:1
This variant has not been reported in the literature in individuals affected with CHRNB2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the CHRNB2 mRNA. The next in-frame methionine is located at codon 61. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1475973). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.